{
  "version": 1,
  "groupId": "meningitis",
  "groupName": "Meningitis",
  "type": "bacterial",
  "updatedAt": "2025-01-14T00:00:00Z",
  "pathogens": [
    {
      "id": "neisseria_meningitidis",
      "name": "Neisseria meningitidis",
      "scientificName": "Neisseria meningitidis (Meningococcus)",
      "definition": "Gram-negative diplococcus causing meningococcal meningitis and septicemia (meningococcemia). N. meningitidis is a leading cause of bacterial meningitis worldwide, with potential for rapid progression and high mortality.",
      "reservoir": {
        "primary": [
          "Human nasopharynx (asymptomatic carriage in 5-10% of population)"
        ],
        "secondary": [
          "Respiratory secretions of carriers"
        ],
        "notes": "Humans are the only reservoir. Asymptomatic nasopharyngeal carriage is common, especially in adolescents and young adults. Only certain strains (serogroups A, B, C, W, X, Y) cause invasive disease."
      },
      "transmission": {
        "mode": "Respiratory droplets",
        "routes": [
          "Respiratory droplets from close contact (coughing, sneezing, kissing)",
          "Direct contact with respiratory secretions",
          "Sharing utensils, drinks, or cigarettes",
          "Close living quarters (dormitories, military barracks, households)"
        ],
        "notes": "Requires close contact (within 1 meter for >8 hours). Transmission is more common in crowded settings."
      },
      "incubationPeriod": {
        "range": "2-10 days (average 4 days)",
        "infectiousPeriod": "Contagious during nasopharyngeal carriage or illness (until 24 hours after effective antibiotic treatment)",
        "seasonality": "Winter and spring peaks in temperate climates; dry season in sub-Saharan Africa (meningitis belt)",
        "geographic": "Worldwide, with highest incidence in sub-Saharan Africa (meningitis belt) and among adolescents/young adults"
      },
      "riskFactors": [
        "Crowding and close contact (dormitories, military barracks, pilgrimage)",
        "Close contacts of cases (household members, kissing contacts)",
        "Immunodeficiency (complement deficiency, HIV)",
        "Asplenia or functional splenectomy",
        "Age (infants, adolescents, young adults)",
        "Active or passive smoking",
        "Recent viral upper respiratory infection"
      ],
      "clinicalFeatures": {
        "symptoms": [
          "Sudden onset of high fever",
          "Severe headache",
          "Stiff neck (nuchal rigidity)",
          "Altered mental status or confusion",
          "Photophobia (sensitivity to light)",
          "Nausea and vomiting",
          "Petechial or purpuric rash (non-blanching) - hallmark of meningococcemia"
        ],
        "complications": [
          "Septic shock and multi-organ failure",
          "Disseminated intravascular coagulation (DIC)",
          "Limb necrosis requiring amputation",
          "Hearing loss and deafness",
          "Neurological sequelae (seizures, cognitive impairment)",
          "Death (10-15% mortality even with treatment; up to 40% without treatment)",
          "Waterhouse-Friderichsen syndrome (adrenal hemorrhage)"
        ],
        "caseDefinition": {
          "suspected": "Patient with sudden onset of fever + headache + stiff neck + altered mental status, OR petechial/purpuric rash + epidemiological link to confirmed case",
          "confirmed": "Clinical illness + laboratory confirmation: positive CSF or blood culture for N. meningitidis, OR positive PCR, OR Gram stain showing Gram-negative diplococci in CSF"
        }
      },
      "diagnosis": [
        "CSF analysis: elevated WBC (neutrophils), low glucose, high protein",
        "CSF culture (gold standard) - chocolate agar with CO2",
        "Blood culture",
        "PCR for N. meningitidis DNA (CSF, blood)",
        "Gram stain of CSF (Gram-negative diplococci)",
        "Latex agglutination or antigen detection"
      ],
      "treatment": "IV penicillin G or ampicillin (if susceptible), OR third-generation cephalosporins (ceftriaxone, cefotaxime - first-line empiric). Supportive care: IV fluids, vasopressors for shock, seizure management. Dexamethasone (adjunct, controversial). Duration: 5-7 days.",
      "infectionControl": {
        "precautions": "Droplet Precautions (surgical mask, private room if possible) until 24 hours after effective antibiotic treatment",
        "screening": "Not routinely recommended; identify close contacts for prophylaxis",
        "cohorting": "Isolate cases; cohort if multiple cases",
        "sourceControl": "Chemoprophylaxis for close contacts (ciprofloxacin, rifampin, or ceftriaxone) within 24 hours",
        "environmental": "Standard cleaning; no special environmental measures needed",
        "staffEducation": "Droplet precautions, recognition of meningococcal disease (petechial rash, rapid progression), contact identification, chemoprophylaxis protocols"
      },
      "outbreakTriggers": [
        "≥2 confirmed cases epidemiologically linked within 3 months in a community or institution",
        "≥3 cases of same serogroup in population <100,000 over 3 months (attack rate >10 per 100,000)",
        "Single case in closed setting (school, dormitory, military barracks) may trigger enhanced surveillance",
        "Cluster above baseline rate"
      ],
      "reportingCommunication": [
        "Immediate notification to public health authorities (within 24 hours or sooner)",
        "Initiate contact tracing and chemoprophylaxis immediately",
        "Vaccination campaigns for at-risk populations (serogroup-specific vaccines)",
        "Public health alerts and media communication",
        "Coordinate with schools, universities, military, or other institutions",
        "Follow national/international outbreak response protocols"
      ],
      "prevention": [
        "Vaccination for at-risk groups: adolescents, college students, military recruits, pilgrims, travelers to endemic areas",
        "Meningococcal vaccines: MenACWY (conjugate), MenB (recombinant)",
        "Awareness of symptoms and rapid healthcare seeking",
        "Chemoprophylaxis for close contacts",
        "Avoid sharing drinks, utensils, or cigarettes",
        "Respiratory hygiene and cough etiquette",
        "Reduce crowding when possible"
      ],
      "references": [
        {
          "label": "WHO - Meningococcal Disease",
          "url": "https://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis"
        },
        {
          "label": "CDC - Meningococcal Disease",
          "url": "https://www.cdc.gov/meningococcal/index.html"
        },
        {
          "label": "Saudi GDIPC - Meningitis Guidelines",
          "url": "https://gdipc.org"
        }
      ]
    },
    {
      "id": "strep_pneumoniae_meningitis",
      "name": "Streptococcus pneumoniae (meningitis)",
      "scientificName": "Streptococcus pneumoniae (Pneumococcus)",
      "definition": "Gram-positive diplococcus causing pneumococcal meningitis, particularly in children and elderly. S. pneumoniae is the most common cause of bacterial meningitis in adults and a leading cause in children, often following respiratory infection or otitis media.",
      "reservoir": {
        "primary": [
          "Human nasopharynx (asymptomatic carriage in 5-10% of adults, 20-40% of children)"
        ],
        "secondary": [
          "Respiratory secretions"
        ],
        "notes": "Humans are the only reservoir. Nasopharyngeal carriage is common, especially in young children. Carriage rates vary by age, season, and vaccination status."
      },
      "transmission": {
        "mode": "Respiratory droplets",
        "routes": [
          "Respiratory droplets from close contact (coughing, sneezing)",
          "Direct contact with respiratory secretions",
          "Autoinoculation from nasopharynx to middle ear or sinuses, then to meninges"
        ],
        "notes": "Meningitis often follows respiratory infection, otitis media, or sinusitis. Transmission is person-to-person via respiratory droplets."
      },
      "incubationPeriod": {
        "range": "1-3 days (variable, often follows upper respiratory infection)",
        "infectiousPeriod": "Contagious during nasopharyngeal carriage or illness",
        "seasonality": "Winter and spring peaks (respiratory season)",
        "geographic": "Worldwide, with higher incidence in developing countries and among unvaccinated populations"
      },
      "riskFactors": [
        "Age extremes (young children <2 years, elderly >65 years)",
        "Immunodeficiency (HIV, complement deficiency, immunosuppressive therapy)",
        "Chronic diseases (diabetes, heart disease, lung disease, liver disease, kidney disease)",
        "Asplenia or functional splenectomy",
        "Cochlear implants or CSF leaks",
        "Recent head trauma or neurosurgery",
        "Smoking and alcohol abuse"
      ],
      "clinicalFeatures": {
        "symptoms": [
          "Fever and chills",
          "Severe headache",
          "Stiff neck (nuchal rigidity)",
          "Altered mental status, confusion, or lethargy",
          "Photophobia",
          "Nausea and vomiting",
          "Seizures (20-30% of cases)"
        ],
        "complications": [
          "Hearing loss and deafness (30% of survivors)",
          "Neurological sequelae (cognitive impairment, seizures, focal deficits)",
          "Brain abscess",
          "Subdural empyema",
          "Hydrocephalus",
          "Death (15-20% mortality in adults; higher in elderly)",
          "Septic shock"
        ],
        "caseDefinition": {
          "suspected": "Patient with fever + headache + stiff neck + altered mental status, often with history of recent respiratory infection, otitis media, or sinusitis",
          "confirmed": "Clinical illness + laboratory confirmation: positive CSF or blood culture for S. pneumoniae, OR positive PCR, OR Gram stain showing Gram-positive diplococci in CSF"
        }
      },
      "diagnosis": [
        "CSF analysis: elevated WBC (neutrophils), low glucose, high protein",
        "CSF culture (gold standard) - blood agar",
        "Blood culture",
        "Gram stain of CSF (Gram-positive diplococci, lancet-shaped)",
        "Pneumococcal antigen detection (urine, CSF)",
        "PCR for S. pneumoniae",
        "CT or MRI brain (to assess complications)"
      ],
      "treatment": "High-dose IV penicillin G or ampicillin (if susceptible), OR third-generation cephalosporins (ceftriaxone, cefotaxime) + vancomycin (empiric for penicillin-resistant strains). Dexamethasone (adjunct, given before or with first antibiotic dose - reduces mortality and hearing loss). Duration: 10-14 days.",
      "infectionControl": {
        "precautions": "Droplet Precautions (surgical mask) for first 24 hours of effective antibiotic treatment; then Standard Precautions",
        "screening": "Not routinely recommended",
        "cohorting": "Isolate cases during first 24 hours of treatment",
        "sourceControl": "Not applicable (no chemoprophylaxis for contacts)",
        "environmental": "Standard cleaning",
        "staffEducation": "Droplet precautions, recognition of meningitis symptoms, vaccination importance, dexamethasone administration timing"
      },
      "outbreakTriggers": [
        "Single confirmed case in closed setting (daycare, nursing home, school)",
        "≥2 epidemiologically linked cases",
        "Cluster above baseline rate",
        "Emergence of vaccine-escape serotypes"
      ],
      "reportingCommunication": [
        "Prompt notification to public health authorities (within 24 hours)",
        "Initiate contact investigation in closed settings",
        "Assess vaccination coverage in affected population",
        "Consider vaccination campaigns if outbreak involves vaccine-preventable serotypes",
        "Update stakeholders and healthcare providers"
      ],
      "prevention": [
        "Vaccination: PCV13 (pneumococcal conjugate vaccine) for children and high-risk adults; PPSV23 (pneumococcal polysaccharide vaccine) for adults ≥65 years and high-risk groups",
        "Awareness of symptoms and rapid healthcare seeking",
        "Respiratory hygiene and cough etiquette",
        "Smoking cessation",
        "Management of chronic diseases",
        "Prompt treatment of respiratory infections, otitis media, and sinusitis"
      ],
      "references": [
        {
          "label": "WHO - Pneumococcal Meningitis",
          "url": "https://www.who.int/news-room/fact-sheets/detail/pneumonia"
        },
        {
          "label": "CDC - Pneumococcal Disease",
          "url": "https://www.cdc.gov/pneumococcal/index.html"
        },
        {
          "label": "Saudi GDIPC - Meningitis Guidelines",
          "url": "https://gdipc.org"
        }
      ]
    },
    {
      "id": "haemophilus_influenzae_b",
      "name": "Haemophilus influenzae type b (Hib)",
      "scientificName": "Haemophilus influenzae type b",
      "definition": "Gram-negative coccobacillus; major cause of childhood meningitis before Hib vaccine. H. influenzae type b was the leading cause of bacterial meningitis in children <5 years before widespread vaccination.",
      "reservoir": {
        "primary": [
          "Human nasopharynx (asymptomatic carriage in 2-5% of children, <1% of adults)"
        ],
        "secondary": [
          "Respiratory secretions"
        ],
        "notes": "Humans are the only reservoir. Carriage rates have dramatically decreased since introduction of Hib vaccine. Non-typeable H. influenzae (NTHi) can also cause invasive disease but is less common."
      },
      "transmission": {
        "mode": "Respiratory droplets",
        "routes": [
          "Respiratory droplets from close contact (coughing, sneezing)",
          "Direct contact with respiratory secretions",
          "Close contact with carriers or cases (household, daycare)"
        ],
        "notes": "Transmission requires close contact. Invasive disease is rare in vaccinated populations."
      },
      "incubationPeriod": {
        "range": "2-4 days (variable)",
        "infectiousPeriod": "Contagious during nasopharyngeal carriage or illness (until 24-48 hours after effective antibiotic treatment)",
        "seasonality": "Fall and winter peaks (respiratory season)",
        "geographic": "Worldwide, with highest incidence in unvaccinated populations and developing countries"
      },
      "riskFactors": [
        "Unvaccinated children <5 years (especially <2 years)",
        "Close contacts of cases (household members, daycare)",
        "Immunodeficiency (HIV, complement deficiency, asplenia)",
        "Crowded living conditions",
        "Lack of breastfeeding",
        "Exposure to tobacco smoke",
        "Cochlear implants or CSF leaks"
      ],
      "clinicalFeatures": {
        "symptoms": [
          "Fever and irritability (especially in infants)",
          "Stiff neck (nuchal rigidity) - may be absent in infants",
          "Lethargy or altered mental status",
          "Poor feeding and vomiting (infants)",
          "Bulging fontanelle (infants)",
          "Seizures",
          "High-pitched cry (infants)"
        ],
        "complications": [
          "Hearing loss and deafness (15-30% of survivors)",
          "Neurological sequelae (developmental delay, cognitive impairment, seizures)",
          "Subdural effusions",
          "Hydrocephalus",
          "Brain abscess",
          "Death (3-6% mortality with treatment; higher without treatment)",
          "Other invasive Hib diseases (epiglottitis, pneumonia, septic arthritis)"
        ],
        "caseDefinition": {
          "suspected": "Child with fever + irritability + stiff neck + lethargy, OR bulging fontanelle (infants) + history of incomplete Hib vaccination or exposure to case",
          "confirmed": "Clinical illness + laboratory confirmation: positive CSF or blood culture for H. influenzae type b, OR positive PCR with serotyping confirming type b"
        }
      },
      "diagnosis": [
        "CSF analysis: elevated WBC (neutrophils), low glucose, high protein",
        "CSF culture (gold standard) - chocolate agar with CO2",
        "Blood culture",
        "Gram stain of CSF (Gram-negative coccobacilli)",
        "PCR for H. influenzae",
        "Serotyping to confirm type b (capsular antigen detection)",
        "Latex agglutination for capsular antigen"
      ],
      "treatment": "Third-generation cephalosporins (ceftriaxone or cefotaxime) - first-line empiric (due to ampicillin resistance). Dexamethasone (adjunct, given before or with first antibiotic dose - reduces hearing loss). Duration: 7-10 days.",
      "infectionControl": {
        "precautions": "Droplet Precautions (surgical mask) until 24 hours after effective antibiotic treatment",
        "screening": "Not routinely recommended; identify close contacts for prophylaxis",
        "cohorting": "Isolate cases during first 24 hours of treatment",
        "sourceControl": "Chemoprophylaxis for close contacts (rifampin) if household includes unvaccinated or incompletely vaccinated children <4 years",
        "environmental": "Standard cleaning",
        "staffEducation": "Droplet precautions, recognition of invasive Hib disease, vaccination importance, contact prophylaxis protocols"
      },
      "outbreakTriggers": [
        "Any confirmed invasive Hib case triggers outbreak investigation (especially in vaccinated populations)",
        "≥2 cases in same community or institution within 60 days",
        "Single case in daycare or household with unvaccinated children",
        "Cluster suggesting vaccine failure or waning immunity"
      ],
      "reportingCommunication": [
        "Urgent notification to public health authorities (within 24 hours)",
        "Implement outbreak control measures immediately",
        "Chemoprophylaxis for household and daycare contacts",
        "Assess vaccination coverage and vaccine failure",
        "Public health alerts and vaccination campaigns if needed",
        "Coordinate with pediatric and infectious disease specialists"
      ],
      "prevention": [
        "Hib vaccination: primary series at 2, 4, 6 months + booster at 12-15 months (part of routine childhood immunization)",
        "Catch-up vaccination for unvaccinated or incompletely vaccinated children",
        "Chemoprophylaxis for close contacts (rifampin)",
        "Respiratory hygiene and cough etiquette",
        "Awareness of symptoms and rapid healthcare seeking",
        "Breastfeeding (protective effect)",
        "Avoid exposure to tobacco smoke"
      ],
      "references": [
        {
          "label": "WHO - Haemophilus influenzae type b (Hib)",
          "url": "https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/haemophilus-influenzae-type-b"
        },
        {
          "label": "CDC - Hib Disease",
          "url": "https://www.cdc.gov/hi-disease/index.html"
        },
        {
          "label": "Saudi GDIPC - Meningitis Guidelines",
          "url": "https://gdipc.org"
        }
      ]
    },
    {
      "id": "listeria_meningitis",
      "name": "Listeria monocytogenes (meningitis)",
      "scientificName": "Listeria monocytogenes",
      "definition": "Gram-positive rod causing neurolisteriosis (meningitis, meningoencephalitis) particularly in neonates, elderly, and immunocompromised. Listeria is a foodborne pathogen with tropism for the central nervous system in vulnerable populations.",
      "reservoir": {
        "primary": [
          "Soil",
          "Water",
          "Contaminated food (ready-to-eat foods, unpasteurized dairy, deli meats)"
        ],
        "secondary": [
          "Food processing environments",
          "Refrigerated foods"
        ],
        "notes": "Listeria is ubiquitous in the environment and can grow at refrigeration temperatures (4°C). Foodborne transmission is the primary route for meningitis."
      },
      "transmission": {
        "mode": "Foodborne ingestion",
        "routes": [
          "Ingestion of contaminated food (ready-to-eat foods, deli meats, soft cheeses, unpasteurized dairy)",
          "Vertical transmission (mother to fetus during pregnancy - neonatal meningitis)",
          "Rarely: direct contact with infected animals or contaminated materials"
        ],
        "notes": "Meningitis occurs after foodborne ingestion with bacteremia and CNS invasion. Neonatal meningitis can occur via vertical transmission or early postnatal exposure."
      },
      "incubationPeriod": {
        "range": "Days to weeks (typically 1-4 weeks for invasive disease; can be up to 70 days)",
        "infectiousPeriod": "Not person-to-person contagious (except vertical transmission during pregnancy)",
        "seasonality": "Year-round, no specific seasonal pattern",
        "geographic": "Worldwide, with higher incidence in developed countries due to consumption of ready-to-eat foods"
      },
      "riskFactors": [
        "Immunocompromised (HIV, cancer, transplant, corticosteroids, biologics)",
        "Age ≥65 years",
        "Pregnancy (risk of vertical transmission to fetus/neonate)",
        "Neonates (early-onset <7 days or late-onset 7-28 days)",
        "Chronic diseases (diabetes, liver disease, kidney disease)",
        "Consumption of high-risk foods (deli meats, soft cheeses, unpasteurized dairy)",
        "Alcoholism"
      ],
      "clinicalFeatures": {
        "symptoms": [
          "Fever and headache",
          "Stiff neck (nuchal rigidity)",
          "Altered mental status, confusion, or lethargy",
          "Seizures",
          "Focal neurological deficits",
          "Ataxia and tremor (rhombencephalitis - brainstem involvement)",
          "Neonates: irritability, poor feeding, lethargy, respiratory distress"
        ],
        "complications": [
          "Meningoencephalitis (combined meningitis and encephalitis)",
          "Rhombencephalitis (brainstem infection) - characteristic of Listeria",
          "Brain abscess",
          "Hydrocephalus",
          "Neurological sequelae (cognitive impairment, seizures, focal deficits)",
          "Death (20-30% mortality in CNS listeriosis)",
          "Neonatal sepsis and death"
        ],
        "caseDefinition": {
          "suspected": "High-risk patient (immunocompromised, elderly, neonate, pregnant) with fever + meningitis/encephalitis symptoms + compatible food exposure history",
          "confirmed": "Clinical illness + laboratory confirmation: positive CSF or blood culture for L. monocytogenes, OR positive PCR from CSF"
        }
      },
      "diagnosis": [
        "CSF analysis: elevated WBC (lymphocytes or neutrophils), low glucose, high protein",
        "CSF culture (gold standard) - may take 48-72 hours",
        "Blood culture",
        "Gram stain of CSF (Gram-positive rods, may be sparse)",
        "PCR for Listeria species",
        "MRI brain (may show rhombencephalitis - brainstem lesions)",
        "Serotyping and molecular subtyping (PFGE, WGS) for outbreak investigation"
      ],
      "treatment": "Ampicillin or penicillin G + gentamicin (synergistic combination) for 3-6 weeks (longer than other bacterial meningitis). Trimethoprim-sulfamethoxazole for penicillin-allergic patients. Supportive care: seizure management, ICP monitoring. Dexamethasone NOT recommended (may reduce ampicillin penetration into CSF).",
      "infectionControl": {
        "precautions": "Standard Precautions (not person-to-person contagious, except vertical transmission)",
        "screening": "Not routinely recommended; test high-risk patients with compatible illness",
        "cohorting": "Not needed (not person-to-person transmission)",
        "sourceControl": "Identify and eliminate contaminated food sources; product recall if outbreak",
        "environmental": "Safe food handling and storage; environmental monitoring in food processing facilities",
        "staffEducation": "Food safety education for high-risk populations, recognition of neurolisteriosis (rhombencephalitis), prolonged treatment duration"
      },
      "outbreakTriggers": [
        "Even a single invasive case (including meningitis) demands public health action",
        "≥2 cases with same molecular subtype (PFGE, WGS)",
        "Cluster of cases with common food exposure",
        "Detection of Listeria in food products or processing environment"
      ],
      "reportingCommunication": [
        "Rapid notification to public health authorities (within 24 hours)",
        "Engage food safety authorities immediately",
        "Coordinate product recall if contaminated food identified",
        "Molecular subtyping (PFGE, WGS) to link cases",
        "Trace-back investigation to identify contaminated products",
        "Public health alerts to high-risk populations"
      ],
      "prevention": [
        "Food hygiene and safety education for vulnerable populations (avoid deli meats, soft cheeses, unpasteurized dairy unless heated)",
        "Proper food handling and storage (refrigeration <4°C slows but does not stop growth)",
        "Pasteurization of milk and dairy products",
        "Reheat ready-to-eat foods to steaming hot (165°F/74°C) before consumption",
        "Environmental monitoring in food processing facilities",
        "Pregnant women should avoid high-risk foods",
        "Cold chain monitoring"
      ],
      "references": [
        {
          "label": "WHO - Listeriosis",
          "url": "https://www.who.int/news-room/fact-sheets/detail/listeriosis"
        },
        {
          "label": "CDC - Listeria Infection",
          "url": "https://www.cdc.gov/listeria/index.html"
        },
        {
          "label": "Saudi GDIPC - Foodborne Illness Guidelines",
          "url": "https://gdipc.org"
        }
      ]
    }
  ]
}